Phil Jevon, PGCE, BSc, RN, is resuscitation officer/clinical skills lead and honorary clinical lecturer, University of Birmingham Medical School Subscribe today for unlimited access to 6,000+ clinical ...
In a multicenter, randomized, double-blind, placebo-controlled, noninferiority trial, we enrolled 5246 men 45 to 80 years of age who had preexisting or a high risk of cardiovascular disease and who ...
Semaglutide, a glucagon-like peptide-1 receptor agonist, has been shown to reduce the risk of adverse cardiovascular events in patients with diabetes. Whether semaglutide can reduce cardiovascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback